|
KIAA0355 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.452480E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.316180E-01 |
| Normal-vs-Stage2 |
1.799970E-01 |
| Normal-vs-Stage3 |
2.542800E-03 |
| Normal-vs-Stage4 |
8.961000E-04 |
| Stage1-vs-Stage2 |
7.711800E-01 |
| Stage1-vs-Stage3 |
2.339700E-02 |
| Stage1-vs-Stage4 |
1.152400E-02 |
| Stage2-vs-Stage3 |
1.831240E-01 |
| Stage2-vs-Stage4 |
1.132780E-01 |
| Stage3-vs-Stage4 |
6.793800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.162800E-03 |
| Normal-vs-AfricanAmerican |
8.953600E-01 |
| Normal-vs-Asian |
3.565000E-01 |
| Caucasian-vs-AfricanAmerican |
1.465630E-01 |
| Caucasian-vs-Asian |
2.552400E-01 |
| AfricanAmerican-vs-Asian |
5.808400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.410400E-02 |
| Normal-vs-Female |
2.228200E-02 |
| Male-vs-Female |
7.223800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.473400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.043560E-02 |
| Normal-vs-Age(61-80Yrs) |
3.919600E-03 |
| Normal-vs-Age(81-100Yrs) |
4.943800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.174200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.009800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.912200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.065000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.800200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.193600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.59519999999302E-05 |
| Classical-VS-Follicular |
3.508200E-01 |
| Classical-VS-Other |
2.430400E-01 |
| Classical-VS-Normal |
1.046210E-01 |
| Tall-VS-Follicular |
3.95579999999951E-05 |
| Tall-VS-Other |
4.839600E-01 |
| Tall-VS-Normal |
1.74090000004679E-06 |
| Follicular-VS-Other |
2.255400E-01 |
| Follicular-VS-Normal |
5.545600E-01 |
| Other-VS-Normal |
4.060300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.468400E-02 |
| Normal-vs-N1 |
6.804600E-03 |
| N0-vs-N1 |
2.006200E-01 |
|
|
